611 related articles for article (PubMed ID: 21516486)
21. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
22. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
[TBL] [Abstract][Full Text] [Related]
24. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
[TBL] [Abstract][Full Text] [Related]
26. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
28. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.
Li J; Tan Q; Yan M; Liu L; Lin H; Zhao F; Bao G; Kong H; Ge C; Zhang F; Yu T; Li J; He X; Yao M
Mol Cancer; 2014 Jul; 13():166. PubMed ID: 24997798
[TBL] [Abstract][Full Text] [Related]
29. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
30. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
Ping W; Jiang WY; Chen WS; Sun W; Fu XN
Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
[TBL] [Abstract][Full Text] [Related]
31. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
32. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
33. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
34. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
[TBL] [Abstract][Full Text] [Related]
36. Expression of TS, RRM1, ERCC1, TUBB3 and STMN1 Genes in Tissues of Non-small Cell Lung Cancer and its Significance in Guiding Postoperative Adjuvant Chemotherapy.
Zou ZQ; Du YY; Sui G; Xu SN
Asian Pac J Cancer Prev; 2015; 16(8):3189-94. PubMed ID: 25921119
[TBL] [Abstract][Full Text] [Related]
37. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
38. Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Agulló-Ortuño MT; Díaz-García CV; Agudo-López A; Pérez C; Cortijo A; Paz-Ares L; López-Ríos F; Pozo F; de Castro J; Cortés-Funes H; López Martín JA
J Cancer Res Clin Oncol; 2015 Jan; 141(1):43-53. PubMed ID: 25081930
[TBL] [Abstract][Full Text] [Related]
39. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.
Liu Z; Mai C; Yang H; Zhen Y; Yu X; Hua S; Wu Q; Jiang Q; Zhang Y; Song X; Fang W
J Cell Mol Med; 2014 Aug; 18(8):1667-79. PubMed ID: 24976536
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
